- Last updated
- reading time
IACM-Bulletin of March 25, 2020
Several laboratory studies suggest that cannabinoids may have antiviral and antibacterial effects. We have reported on this repeatedly in the IACM-Bulletin.
However, there is no evidence that individual cannabinoids -- such as CBD, CBG or THC -- or cannabis preparations protect against infection with the SARS-CoV2 virus or could be used to treat Covid-19, the disease produced by this virus.
Also, there is no evidence that the use of cannabinoids could increase the risk of viral infection.
Please do not pass on false information that is circulating on the Internet. Help contain the spread of the virus by following government and health authority guidelines.
Let us be in solidarity during this time, especially with those who are particularly at risk from such an infection.
Take care of yourself and others!
On behalf of the IACM Board of Directors
Dr. Kirsten Müller-Vahl (1st Chairwomen)
Dr. Franjo Grotenhermen (Executive Director)